tis is a safehaven

It is at times like these that believers in the fundamentals of this stock have to stand firm.

This stock does have risks BUT it always did and nothing that has occurred today in the market has changed that.

Diabetic ulcers will not decrease if the world goes into recession. Indeed, as this treatment will be cheaper and more effective than comparable treatments, it will increase demand for TIS's products.

When we get our commercial deal (finally), this stock will be a winner irrespective of the global economic situation.

Hang in there all.